Gelonghui, Feb. 28, 丨 Shenlian Biotech (688098.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved operating income of 301.4871 million yuan, down 8.25% from the previous year; net profit attributable to owners of the parent company was 31.518,700 yuan, down 48.42% from the previous year.
申联生物(688098.SH)：2023年度净利润3151.87万元 同比下降48.42%
Shenlian Biotech (688098.SH): 2023 net profit of 31,518,700 yuan decreased by 48.42% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.